CION Cancer Clinics
Multifocal HCC: is it spread, or several new tumours? | CION Cancer Clinics
Several tumours in the liver can come from one cancer that spread through the liver's blood vessels, or from separate new cancers growing in a liver damaged by cirrhosis or hepatitis. Often it is a mix of both. This page explains the two patterns, the clues on a scan report, and why the plan depends more on the tumours and your liver than on the label. At CION Cancer Clinics in Hyderabad, our oncologists explain liver cancer in plain words and plan care around you and your family.
On this page
- Is multifocal HCC one cancer that spread, or several new ones?
- How can one liver end up with several tumours?
- Which words on the scan report point one way or the other?
- What will the doctors do once several tumours are found?
- What do families often get wrong about several liver tumours?
- Does it change treatment whether they spread or started separately?
- What this page cannot tell you
- Common questions about multifocal HCC
The short answer
Is multifocal HCC one cancer that spread, or several new ones?
It can be either, and often it is a mix of both. Some of the extra tumours are seeds from one main tumour that travelled through the liver's own blood vessels. Others are separate cancers that started on their own, because the whole liver was damaged by cirrhosis or hepatitis.
What multifocal means on your report
Multifocal simply means more than one tumour inside the liver. It describes how many there are. It does not say how they got there, and it does not by itself mean the cancer has gone outside the liver.
This page is about primary liver cancer
Hepatocellular carcinoma (HCC) is cancer that starts in the liver cells themselves. If your report says several spots in the liver and you have had cancer of the bowel, breast, stomach or pancreas, those spots are more likely to be secondary liver cancer, which is a different illness with a different plan.
Multifocal describes the count. It is not a stage on its own, and it does not decide treatment on its own.Two ways it happens
How can one liver end up with several tumours?
Doctors describe two patterns. Both can be present in the same person at the same time.
Spread inside the liver
One main tumour grows into the small branches of the portal vein, the vessel that carries blood into the liver. Cells break off and lodge nearby. Doctors call this intrahepatic metastasis.
Often looks like
- One large tumour with smaller satellites close by
- Satellites in the same part of the liver
- Signs that the tumour has entered a blood vessel
New tumours starting separately
A liver scarred by years of hepatitis B, hepatitis C, alcohol or fatty liver can grow cancers in more than one place, independently. Doctors call this multicentric HCC.
Often looks like
- Small tumours of similar size in different parts
- Early-looking nodules growing inside other nodules
- A background of cirrhosis on the scan
Why the damaged liver matters
The tumours share one cause: the liver underneath. That is why a tumour can be treated well and a new one can still appear years later in a different spot. Read why HCC starts in a damaged liver for more on this.
Why the label is usually uncertain
Scans give strong clues, but they cannot prove which pattern you have. Your team treats what it can see and plans follow-up for what may come next.
Not sure whether this applies to you?
Ask an oncologistOn your report
Which words on the scan report point one way or the other?
- Satellite nodule
- A small tumour sitting close to a larger one. It usually suggests the main tumour has seeded nearby.
- Vascular invasion
- The tumour has grown into a blood vessel, often a branch of the portal vein. It favours spread from one tumour and matters a great deal for planning.
- Nodule-in-nodule
- An early cancer forming inside a non-cancerous nodule. It suggests a new tumour starting by itself.
- Arterial enhancement and washout
- How a nodule lights up and then fades on a contrast scan. This pattern is how HCC is recognised on CT or MRI, and each nodule is judged on its own.
- LI-RADS
- A scoring system for how likely each liver nodule is to be HCC. Several nodules may carry different scores. See LI-RADS explained.
- Bilobar
- Tumours in both the right and left halves of the liver. This affects which treatments can reach all of them.
What happens next
What will the doctors do once several tumours are found?
Count and map every tumour
A good-quality triple-phase CT or liver MRI shows how many tumours there are, how big each is, and which part of the liver holds them. CION arranges these scans through accredited diagnostic partners.
Check the blood vessels and outside the liver
The radiologist looks for tumour inside the portal vein and for any spread to the lungs, bones or lymph nodes. This often changes the plan more than the count does.
Measure liver function
Blood tests such as bilirubin, albumin and INR show how well the liver works. A tumour that could be treated in a strong liver may not be safe to treat in a weak one.
Discuss it at the tumour board
Oncologists, surgeons, radiologists and hepatologists review the scans together at the liver tumour board. They agree a plan that fits the tumours, the liver and your fitness.
Plan follow-up for new tumours
Because new tumours can keep appearing in a damaged liver, regular scans after treatment are part of the plan from the start.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often get wrong about several liver tumours?
Not necessarily. A few small tumours in a liver that still works well can sometimes be treated with ablation, surgery or a transplant. Staging weighs the tumours, the liver and your fitness together.
Surgery suits only some people. When tumours are spread across the liver, treatments that reach the whole liver, such as TACE or medicines, are often more suitable.
Often it means the damaged liver grew a fresh cancer in a new place. That is why follow-up scans continue, and why a new tumour found early can often be treated again.
Multifocal describes tumours inside the liver only. Spread outside the liver is a separate finding, and your report will say so in its own words.
Side by side
Does it change treatment whether they spread or started separately?
Being straight with you
What this page cannot tell you
It cannot tell you which pattern your tumours follow. Even specialists looking at the same scan often cannot be certain, and testing tumour DNA to settle the question is mostly done in research. In practice the plan depends on the number, size and position of the tumours, the blood vessels and the liver, more than on the label.
It cannot stage you or choose a treatment
Whether several tumours fit transplant criteria, or suit ablation, TACE or medicines, is decided by a team that has seen your scans and blood results together.
Who this does not apply to
This page does not apply if your liver spots came from cancer elsewhere in the body, or if you have a bile duct cancer such as cholangiocarcinoma. It also does not apply to a child, where liver tumours are usually a different disease.
If you have a report listing several liver tumours, bring the scan images and the report to a consultation. A second look at the images is often worth more than a second reading of the words.Questions we are asked
Common questions about multifocal HCC
Is multifocal HCC worse than a single tumour?
In general, more tumours narrow the treatment choices, because fewer treatments can reach all of them safely. But the number is only one part of the picture. Tumour size, blood vessel involvement and how well your liver works often matter just as much. Your team will explain how these fit together for you.
Can several liver tumours still be treated with curative intent?
Sometimes. A small number of small tumours in a liver that works well may suit a transplant, ablation or surgery, which are treatments given with curative intent. Larger or more numerous tumours are usually treated to control them. The tumour board decides which applies to you.
Can a biopsy tell if the tumours are linked?
Usually not in everyday care. A biopsy can confirm that a nodule is HCC, but comparing the DNA of several tumours to see if they share a parent is mainly a research tool. HCC is often diagnosed from the scan pattern alone, without any biopsy.
Why did new tumours appear after my surgery or ablation?
Either some cells had already spread before treatment and were too small to see, or the damaged liver grew a new cancer. Both are common. This is why follow-up scans continue after treatment, and why a tumour found early on follow-up can often be treated again.
Does treating hepatitis B or C lower the chance of new tumours?
Controlling hepatitis B or clearing hepatitis C is thought to lower the chance of new cancers forming in the liver, but it does not remove it. Antiviral decisions belong to a hepatologist or physician, and CION coordinates that care alongside cancer treatment.
Is TACE used when there are many tumours?
Often, yes. TACE delivers treatment through the liver's arteries and can reach several tumours in one area or across the liver. It suits people whose liver still works reasonably well. CION coordinates TACE through accredited partner hospitals with interventional radiology.
Should my family be checked if I have several tumours?
The number of tumours does not change the family question. What matters is the cause of your liver damage. If it was hepatitis B, household members should be tested and vaccinated if they are not protected, without any blame on anyone.
How do I get my scans reviewed by a liver team?
Collect the scan images on a disc or link, the written reports and recent blood results. Call the CION helpline and ask for a liver cancer consultation or second opinion. The tumour board can review the images and explain what they show and what can be done.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
- American Cancer Society — Liver Cancer Stages
- Cancer Research UK — Stages of liver cancer
- MedlinePlus — Liver cancer - hepatocellular carcinoma
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Have a report that lists several liver tumours?
Send us the scan images and reports, and our liver tumour board can look at them together and explain what they show. One helpline serves every CION centre.